Skip to main content
Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc. — Investor Relations & Filings

Ticker · MCRB ISIN · US81750R2013 LEI · 549300GMXBE5NUWISF13 US Manufacturing
Open in API
Filings indexed 668 across all filing types
Latest filing 2021-06-01 Director's Dealing
Country US United States of America
Listing US MCRB

About Seres Therapeutics, Inc.

https://www.serestherapeutics.com/

Seres Therapeutics, Inc. is a commercial-stage biotechnology company developing microbiome-based therapeutics. The company's platform creates a novel class of biological drugs, known as live biotherapeutics, which consist of rationally selected consortia of live bacteria. These therapies are designed to modulate the functional properties of the gastrointestinal microbiome to treat and prevent diseases. Seres' development programs target medically vulnerable patient populations, with a focus on preventing bacterial bloodstream and antimicrobial-resistant (AMR) infections, as well as treating gastrointestinal-related immune diseases.

Recent filings

Filing Released Lang Actions
FORM 3 SUBMISSION
Director's Dealing
2021-06-01 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement, specifically a Sales Agreement for an 'at the market' equity offering program to raise up to $150 million. It includes details about the agreement, parties involved, and legal opinions. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document is primarily an announcement of a capital raising agreement and related financing activity. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the financing event, not just a brief notice or regulatory filing. Hence, the classification is CAP with high confidence.
2021-05-21 English
424B5
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to a shelf registration statement for the sale of common stock. It includes detailed information about the offering, registration fee calculation, sales agreement, and incorporation by reference of other SEC filings such as the Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and Current Reports on Form 8-K. The document is a registration and offering prospectus supplement, which is a type of capital raising disclosure. It is not an annual report, earnings release, or any other financial report but rather a detailed disclosure related to a capital raising transaction. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief summary, supporting a high confidence level.
2021-05-21 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated May 20, 2021, by Seres Therapeutics, Inc. The content focuses on the appointment of a new executive officer, David Arkowitz, as Executive Vice President, Chief Financial Officer, and Head of Business Development. It details his background, employment agreement, compensation, and terms of termination. There is no financial data or report content; rather, it is an announcement of a management change. According to the filing definitions, announcements of changes in senior management fall under Board/Management Information (MANG). The document is not a full financial report, earnings release, or regulatory filing of another type. Therefore, the correct classification is MANG with high confidence.
2021-05-20 English
FORM 4 SUBMISSION
Director's Dealing
2021-05-19 English
SCHEDULE 13G
Major Shareholding Notification
2021-05-05 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.